Parkinson Disease Clinical Trials in Miami, Florida

9 studies are recruiting for parkinson disease in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

   This is a Phase 2 study in people with Parkinson's disease who experience motor fluctuations while taking levodopa. The study will evaluate how effective two different doses of the study drug AP-472 are when added to levodopa treatment, compared with a placebo. The study will last about 12 weeks. P…

   Stage

   Phase 2

   Ages

   30 to 80

   Site

   University of Miami (Site #220), Miami, Florida

   Locations

   30 in total

   Run by

   Appello Pharmaceuticals, Inc.

   See if you can join NCT07432958 on ClinicalTrials.gov

2. Deep Brain Stimulation (DBS) Retrospective Outcomes Study

   The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

   Stage

   Not phased

   Ages

   Any age

   Site

   University of Miami Hospital, Miami, Florida

   Locations

   20 in total

   Run by

   Boston Scientific Corporation

   See if you can join NCT03664609 on ClinicalTrials.gov

3. Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

   This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.

   Stage

   Phase 2

   Ages

   30 and older

   Site

   NextGen Research Group, Miami, Florida

   Locations

   4 in total

   Run by

   Gateway Institute for Brain Research

   See if you can join NCT05266417 on ClinicalTrials.gov

4. A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

   The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.

   Stage

   Phase 2

   Ages

   45 to 75

   Site

   University of Miami, Miami, Florida

   Locations

   46 in total

   Run by

   AskBio Inc

   See if you can join NCT06285643 on ClinicalTrials.gov

5. Use of CereGate Therapy for Freezing of Gait in PD

   A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.

   Stage

   Not phased

   Ages

   21 to 80

   Site

   University of Miami, Miami, Florida

   Locations

   7 in total

   Run by

   CereGate Inc.

   See if you can join NCT05292794 on ClinicalTrials.gov

6. Abbott DBS Post-Market Study of Outcomes for Indications Over Time

   The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.

   Stage

   Not phased

   Ages

   Any age

   Site

   University of Miami Hospital, Miami, Florida

   Locations

   48 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT04071847 on ClinicalTrials.gov

7. A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

   The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).

   Stage

   Phase 4

   Ages

   18 and older

   Site

   University of Miami, Miami, Florida

   Locations

   27 in total

   Run by

   Impax Laboratories, LLC

   See if you can join NCT06765668 on ClinicalTrials.gov

8. Longitudinal Cognitive Assessment by BoCA

   The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis t…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Andrey Vyshedskiy, Miami, Florida

   Run by

   Alzheimer's Light LLC

   See if you can join NCT04114994 on ClinicalTrials.gov

9. Parkinson's Foundation Surveys

   Parkinson's Foundation Surveys is an initiative seeking to periodically survey people with Parkinson's disease (PD), their care partners and medical professionals to better understand specific aspects of living with PD.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Parkinson's Foundation, Miami, Florida

   Run by

   Parkinson's Foundation

   See if you can join NCT05066763 on ClinicalTrials.gov